Renal function in transfusion-dependent pediatric beta-thalassemia major patients

被引:18
|
作者
Jalali, Amir [1 ]
Khalilian, Hamid [2 ]
Ahmadzadeh, Ali [2 ]
Sarvestani, Somie [1 ]
Rahim, Fakher [3 ]
Zandian, Khodamorad [2 ]
Asar, Shideh [2 ]
机构
[1] Ahvaz Jundishapur Univ Med Sci, Dept Pharmacol & Toxicol, Sch Pharm, Toxicol Res Ctr, Ahvaz, Iran
[2] Ahvaz Jundishapur Univ Med Sci, Dept Pediat Nephrol, Abuzar Hosp, Ahvaz, Iran
[3] Ahvaz Jundishapur Univ Med Sci, Physiol Res Ctr, Ahvaz, Iran
关键词
Urinary NAG; Beta-thalassemia major; Renal tubular dysfunction; Glomerular function; TUBULAR DYSFUNCTION; D-GLUCOSAMINIDASE; EXCRETION; MARKERS;
D O I
10.1179/102453311X12953015767662
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose: In this study, the relationship between glomerular and tubular function and creatinine, glomerular filtration rate (GFR) and urine NAG in thalassemia major patients aged 7-16 years was investigated. Design and setting: This is a case-control study comprising 280 individuals [144 (51.4%), males; 136 (48.6%), females]. Materials and methods: Patients were divided in groups of 14 individuals and age groups of 7-16 years. Sodium excretion fraction, fraction excretion of potassium, calcium-to-creatinine and uric acid-to-creatinine ratios, and duration of specific blood transfusion were determined in all age groups receiving deferoxamine. Results: GFR decreased with increasing age, but the correlation was not statistically significant. There was no significant correlation between the ferritin levels and the GFR changes. The mean value of NAG activity between thalassemic patients and controls has no significant difference. The difference in mean age of the groups with high NAG activity and normal NAG activity was statistically significant. Thirty-seven patients (52.1%) in the group with normal NAG activity, and 45 patients (6.25%) in the group with NAG activity above normal were observed with uricosuric effects with no significant difference. Four patients (6.9%) in the group with normal NAG activity and six patients (7.3%) in the group with NAG activity above normal were shown to have hematuria with no significant difference. The results show that the increase in serum ferritin is significantly correlated with the increase in NAG activity (P < 0.001, r=0.2). Of patients with normal NAG activity 1 (1.7%) and with NAG activity higher than normal, 13 (15.9%) cases experienced hypercalciuria that significant difference was existing. The data also indicated that the NAG changes do not correlate with GFR changes. Conclusion: The results showed that kidney dysfunction in thalassemia increases with increasing age, duration, and levels of blood transfusion and hypercalciuria. It is therefore recommended that the presence of severe renal dysfunction in thalassemic patients should be investigated using sensitive and specific tests, mainly NAG, to prevent progress towards the complications.
引用
收藏
页码:249 / 254
页数:6
相关论文
共 50 条
  • [41] Urethral meatus edema with peno-scrotal edema in a patient with transfusion-dependent beta-thalassemia major
    Nasrallah, Oussama G.
    Mahdi, Jana H.
    Bachir, Bassel G.
    [J]. CLINICAL CASE REPORTS, 2024, 12 (03):
  • [42] Pulmonary Function Test in Transfusion-Dependent β-Thalassemia Major Patients: A Pilot Study
    Alyasin, Soheila
    Moghtaderi, Mozhgan
    Amin, Reza
    Kashef, Sara
    Karimi, Mehran
    [J]. PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2011, 28 (04) : 329 - 333
  • [43] A commentary on molecular basis of transfusion dependent beta-thalassemia major patients in Sabah
    Iswari Setianingsih
    [J]. Journal of Human Genetics, 2014, 59 : 173 - 173
  • [44] A commentary on molecular basis of transfusion dependent beta-thalassemia major patients in Sabah
    Setianingsih, Iswari
    [J]. JOURNAL OF HUMAN GENETICS, 2014, 59 (04) : 173 - 173
  • [45] Retrospective Evaluation of Oral Glucose Tolerance Test in Young Patients with Transfusion-Dependent Beta-Thalassemia
    Dritsa, Maria
    Economou, Marina
    Perifanis, Vasilios
    Teli, Aikaterini
    Christoforidis, Athanasios
    [J]. ACTA HAEMATOLOGICA, 2022,
  • [46] Clinical and histological evaluation of liver disease in patients with transfusion-dependent beta-thalassemia: A multicenter study
    Prati, D
    Maggioni, M
    Rebulla, P
    Morelli, G
    Coggi, G
    Cappellini, MD
    [J]. JOURNAL OF HEPATOLOGY, 2003, 38 : 163 - 164
  • [47] Optical coherence tomography angiography findings in transfusion-dependent beta-thalassemia patients with and without splenectomy
    Koctekin, Belkis
    Karakus, Volkan
    Dogan, Berna
    Erdem, Ramazan
    Dogan, Ugur
    Buber, Hakan
    Kurtoglu, Erdal
    [J]. PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY, 2023, 42
  • [48] LONG-TERM INTRAVENOUS DEFEROXAMINE TREATMENT FOR NONCOMPLIANT TRANSFUSION-DEPENDENT BETA-THALASSEMIA PATIENTS
    TAMARY, H
    GOSHEN, J
    CARMI, D
    YANIV, I
    KAPLINSKY, C
    COHEN, IJ
    ZAIZOV, R
    [J]. ISRAEL JOURNAL OF MEDICAL SCIENCES, 1994, 30 (08): : 658 - 664
  • [49] WILLINGNESS TO PAY FOR TEMPORARY ALLEVIATION OF ANEMIA STATUS TRANSFUSION-DEPENDENT BETA-THALASSEMIA PATIENTS IN CHINA
    Chen, S.
    Liu, Y.
    Huang, R.
    Jia, Y.
    Wang, X.
    Xi, X.
    [J]. VALUE IN HEALTH, 2024, 27 (06) : S316 - S316
  • [50] Impaired bone marrow microenvironment and stem cells in transfusion-dependent beta-thalassemia
    Zhou, Xiaoya
    Huang, Li
    Wu, Jieying
    Qu, Yuhua
    Jiang, Hua
    Zhang, Jinqiu
    Qiu, SiYuan
    Liao, Can
    Xu, Xiang
    Xia, Jianchuan
    Lian, Qizhou
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2022, 146